Inside Innovation

Atossa Therapeutics, a Seattle-based biotech company, paid $3 million for exclusive rights to negotiate an acquisition of an unnamed company in the pre-clinical stages of

A COVID-19 vaccine developed by UW Medicine researchers is the first COVID therapeutic technology from the Seattle health care system to be approved for patient

Seattle juggernauts Fred Hutch Cancer Research Center and Amazon are joining forces to develop early-stage cancer vaccine trials. Fred Hutch will leverage Amazon’s machine learning

Seattle’s life science industry is booming. With top institutions such as Fred Hutchinson Cancer Research Center, the Allen Institute for Brain Science and the Institute

Three Seattle-based biotech startups are coming together to support the open-access development of protein folding and design software in a new project called OpenFold. Cyrus

A new 197,000 square-foot life sciences building is under construction in Seattle to alleviate the increased demand for lab space. Seattle is part of a

Phase Genomics, a Seattle-based DNA analysis startup, has received $5.5 million in funding from the Bill & Melinda Gates Foundation and the U.S. National Institutes

According to a new report by CBRE, Seattle ranks ninth out of the top 25 research talent clusters in the U.S. The 2022 Life Sciences

The Seattle Children’s Research Institute has announced a new program featuring scientists from historically underrepresented backgrounds. Over the next five years, the $45 million initiative

Adaptive Biotechnologies, a Seattle-based life science company, has revealed a new Lyme disease test that has the ability to detect the disease in its early

Dr. Tom Lynch, President and Director at Fred Hutchinson Cancer Center, believes the future of cancer research is in data science. The Seattle-based nonprofit is

A Seattle-based startup, Talus Bioscience, raised $9.75 million in funding to help advance its drug discovery platform to find compounds affecting gene activity, which have